Post-marketing Surveillance of Bixalomer in Patients With Pre-dialysis Chronic Kidney Disease
NCT02805348 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 144
Last updated 2024-10-16
Summary
The objective of this study is to assess the long-term safety and efficacy of bixalomer under post-marketed setting.
Conditions
Interventions
- DRUG
-
Bixalomer
Oral
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Inc
Eligibility
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-01
- Primary Completion
- 2018-12-31
- Completion
- 2018-12-31
Countries
- Japan
Study Locations
More Related Trials
-
A Study to Learn About How Well BAY3283142 Works and Its Safety in Participants With Chronic Kidney Disease
NCT06522997 ·Status: COMPLETED ·Phase: PHASE2
-
Long-term Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
NCT00892749 ·Status: COMPLETED ·Phase: PHASE3
-
Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis
NCT01872026 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Study in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
NCT01742611 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Learn How the Body Processes the Study Medicine PF-07328948 in People With Reduced Kidney Function
NCT07315360 ·Status: RECRUITING ·Phase: PHASE1
-
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1)
NCT00500682 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy, Safety and Tolerability of Balcinrenone/Dapagliflozin Compared to Dapagliflozin in Adults With Chronic Kidney Disease
NCT06350123 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2)
NCT00501046 ·Status: COMPLETED ·Phase: PHASE3
-
A Study to Assess the Tolerability and Efficacy of AKST1210 in Patients on Hemodialysis With Cognitive Impairment
NCT04527328 ·Status: COMPLETED ·Phase: NA
-
ASP8825 - Pharmacokinetics Study in Patients With Impaired Renal Function and Haemodialysis
NCT02629224 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia Not on Dialysis
NCT01742585 ·Status: COMPLETED ·Phase: PHASE3
-
Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.
NCT05358106 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 1 Study of Roxadustat in Subjects With Different Degrees of Renal Function
NCT02965040 ·Status: COMPLETED ·Phase: PHASE1
-
HEPLISAV-B® in Adults With End-Stage Renal Disease (ESRD) Undergoing Hemodialysis
NCT03934736 ·Status: COMPLETED ·Phase: PHASE1
-
A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on Hemodialysis
NCT01057407 ·Status: COMPLETED ·Phase: PHASE3
-
End-stage Renal Disease (ESRD) Pilot Study
NCT03787368 ·Status: COMPLETED ·Phase: PHASE1
-
To Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of KN060 in ESRD Dialysis Patients
NCT07201467 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
A Study to Learn How the Study Treatment BAY3283142 Taken as Single Dose by Mouth Moves Into, Through, and Out of the Body, How Safe it is, and How it Affects the Body in Participants With Reduced Kidney Function Compared to Participants With Normal Kidney Function of Similar Age, Gender, and Weight
NCT05515432 ·Status: COMPLETED ·Phase: PHASE1
-
A Study to Evaluate the Safety, Tolerability, and Effects on Blood and Urine Markers of Single Ascending Dose of GSK4771261 in Healthy Participants and Participants With Autosomal Dominant Polycystic Kidney Disease
NCT06734234 ·Status: RECRUITING ·Phase: PHASE1
-
Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation
NCT03373461 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Evaluate BMS-986278 in Participants With Normal Renal Function, Severe Renal Impairment, or End-Stage Renal Disease on Intermittent Hemodialysis
NCT06723535 ·Status: COMPLETED ·Phase: PHASE1
-
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
NCT02912533 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of LY3113593 in Participants With Chronic Kidney Disease
NCT02604160 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on Hemodialysis
NCT02965053 ·Status: COMPLETED ·Phase: PHASE1
-
A Phase 3 Study in Patients With Chronic Kidney Disease and Hyperphosphatemia on Peritoneal Dialysis
NCT01017276 ·Status: COMPLETED ·Phase: PHASE3